BIGG

Total: 2198

Tubaka- või nikotiinitoodetest loobumise nõustamine
Counseling to quit tobacco or nicotine products

The use of tobacco and nicotine products is one of the major preventable health risk factors, resulting in over 8 million deaths per year worldwide (1). Quitting tobacco or nicotine products is important in the prevention and treatment of many chronic diseases, because it improves the quality of life of ...

Guía de práctica clínica para el tratamiento farmacológico de nefritis lúpica

La nefritis lúpica (NL) es un tipo de glomerulonefritis que se desarrolla como consecuencia del lupus eritematoso sistémico (LES), una enfermedad autoinmune sistémica de presentación clínica variable (1, 2). La NL se clasifica histológicamente en seis clases(I-VI) (3), las cuales poseen diferentes ...

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (‎HPV)‎

This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. This document includes guidance on an important additional option for cervical screening, the use of mRNA (messenger RNA) HPV testing. This gives countries a...

Headaches in over 12s: diagnosis and management: Last updated 17 December 2021

This guideline covers advice on the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and mana...

Prostate cancer: diagnosis and management

This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow up in primary care for people...

Colorectal cancer: Last updated 15 December 2021

This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and secondary tumours (metastatic disease). The recommendations in this guideline were developed befor...

Suspected cancer: recognition and referral: Last updated 15 December 2021

This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that ...

Časná diagnostika a léčba chronické virové hepatitidy C (VHC)
Early diagnosis and treatment of chronic hepatitis C virus (HCV)

According to WHO data, 71 million people worldwide were infected with hepatitis C virus (HCV) in 2015, corresponding to a prevalence of 1%. 399,000 people die annually from complications of liver cirrhosis, including hepatocellular carcinoma. This KDP answers the following clinical questions: Diagnos...

Pelvic floor dysfunction: prevention and non-surgical management

This guideline covers the prevention, assessment and non-surgical management of pelvic floor dysfunction in women aged 12 and over. It aims to raise awareness and help women to reduce their risk of pelvic floor dysfunction. For women who have pelvic floor dysfunction, the guideline recommends interventio...

WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia

In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. This decision was based on new evidence on the ...